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DNA damageMutations in the gene encoding cytosolic Cu,Zn-superoxide dismutase (SOD1) have been linked to familial
amyotrophic lateral sclerosis (FALS). However the molecular mechanisms of motor neuron death are multi-
factorial and remain unclear. Here we examined DNA damage, p53 activity and apoptosis in SH-SY5Y human
neuroblastoma cells transfected to achieve low-level expression of either wild-type or mutant Gly93→Ala
(G93A) SOD1, typical of FALS. DNA damage was investigated by evaluating the levels of 8-oxo-7,8-dihydro-
2′-deoxyguanosine (8-oxodGuo) and DNA strand breaks. Signiﬁcantly higher levels of DNA damage,
increased p53 activity, and a greater percentage of apoptotic cells were observed in SH-SY5Y cells transfected
with G93A SOD1 when compared to cells overexpressing wild-type SOD1 and untransfected cells. Western
blot, FACS, and confocal microscopy analysis demonstrated that G93A SOD1 is present in the nucleus in
association with DNA. Nuclear G93A SOD1 has identical superoxide dismutase activity but displays increased
peroxidase activity when compared to wild-type SOD1. These results indicate that the G93A mutant SOD1
association with DNA might induce DNA damage and trigger the apoptotic response by activating p53. This
toxic activity of mutant SOD1 in the nucleus may play an important role in the complex mechanisms
associated with motor neuron death observed in ALS pathogenesis.S, amyotrophic lateral sclerosis;
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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
characterized by progressive loss of motor neurons, leading to muscle
atrophy, paralysis, and death [1,2]. The majority of cases are sporadic
with unknown causes, but around 10% are familial inherited forms
(FALS) [3]. About 25% of FALS cases are associated with mutations
in the gene encoding cytosolic Cu,Zn-superoxide dismutase (SOD1), a
very abundant antioxidant enzyme in the central nervous system [4].
Currently, more than a hundred point mutations in the sod1 gene have
been found in FALS patients [5]; however, the reason these mutations
cause motor neuron death remains an unanswered question. There is
no clear correlation between enzyme activity, clinical progression, anddisease phenotype, since most mutants retain full catalytic activity
[6,7]. The Gly93→Ala (G93A) mutation is one of the most studied
mutations worldwide due to the availability of G93A SOD1 transgenic
animals [8]. Mice and rats overexpressing human G93A SOD1, as well
as other FALSmutations, develop very similar features to ALS patients,
with progressive motor neuron degeneration, reviewed in [9], while
SOD1 knockout mice do not develop motor neuron disease [10]. The
autosomal dominant nature of SOD1-associated FALS suggests a toxic
gain of function for the mutant enzyme. Currently, it is known that
FALS-linked SOD1 mutants tend to form toxic aggregates and cause
oxidative molecular damage and mitochondrial dysfunction, conse-
quently triggering apoptosis in neuronal cells, reviewed in [11]. The
toxicity of mutant SOD1 seems to precede aggregation [12–14], and
may be explained by its increased ability to promote the oxidation of
biomolecules. SOD1-mediated oxidation can occur via its peroxidase
activity, reviewed in [15] but its role in ALS remains controversial.
The unambiguous fact is that accumulation of oxidatively generated
damage to proteins, lipids, andDNAoccurs in ALS patients and in SOD1
G93A animal models, reviewed in [16].
The toxicity of FALS-mutant SOD1 has been largely associated with
its recruitment to mitochondria [17–19], leading to respiratory failure
[20,21] and activation of the apoptotic cascade [22,23]. A recent study
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endoplasmic reticulum (ER) stress [24,25]. Nuclear apoptotic mecha-
nisms have been less explored. Nuclear p53 protein triggers apoptosis
as a consequence of the accumulation of DNA damage [26], but the
mechanism underlying this phenomenon is not fully understood.
p53 is phosphorylated and subsequently activated by the ataxia–
telangiectasia mutated (ATM) protein upon binding to a DNA double-
strand break. Activated p53 upregulates the bax pro-apoptotic gene and
inhibits the bcl-2 anti-apoptotic gene [27]. The response to other forms
of DNA damage that generates single-stranded regions is coordinated
mainly by ataxia–telangiectasia and Rad3-related protein kinases
(ATR). ATR associates with claspin and phosphorylates downstream
substrates including p53 [28]. Increased levels of p53were found in ALS
patients and animal models [29–31], but a direct relationship between
p53 levels and DNA damage has never been sought. Increased levels of
8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodGuo), a product of DNA
oxidation, were found in the spinal cord and motor cortex of ALS
patients [33–35]. Furthermore, increased levels of free 8-oxodGuo in
the urine, plasma, and cerebrospinal ﬂuid of ALS patients correlated
with disease progression and severity [36].
In the present work, we examined dismutase and peroxidase SOD1
activity in total cellular and nuclear extracts obtained from SH-SY5Y
human neuroblastoma cells transfected with either wild-type SOD1
or the G93A FALS-mutant SOD1. SOD1 peroxidase activity positively
correlated with DNA damage in these cells, as assessed by the levels of
8-oxodGuo as well as by strand break formation. p53 activity and
apoptosis were also evaluated in these cells. Our results demonstrate a
toxic activity for mutant SOD1 in the nucleus, indicating that DNA
damage may play an important role in the pathogenesis of ALS.
2. Materials and methods
2.1. Chemicals
All the chemicals employed in the present study were of the highest
commercially available purity grade. Chromatography grade methanol,
formic acid, chloroform, ethanol, and 2-chloroacetaldehyde were
acquired from Merck (Darmstadt, Germany). Hydrogen peroxide was
from Fluka Chemika (Buchs, Switzerland). Fetal bovine serum and
Dulbecco's MEM-HAM F12 medium were purchased from Cultilab
(Campinas, Brazil). Deferoxamine mesylate salt was from Ciba-Geigy
(Basel, Switzerland). Geneticin was from Gibco (Paisley, UK). All other
chemicals were from Sigma (St. Louis, MO). Water was puriﬁed using a
Milli-Q system (Millipore, Bedford, MA).
2.2. Cell culture
SH-SY5Y human neuroblastoma cells were purchased from the
European Collection of Cell Culture and grown at 37 °C in Dulbecco's
MEM-HAMF12 supplementedwith15% fetal calf serum, 3.7 g/L sodium
bicarbonate, 40 mg of penicillin/L, and 100 mg of streptomycin/L in an
atmosphere of 5% CO2 in air. Clonal cell lines transfected with either
humanwild-type SOD1, G93A or H46Rmutants SOD1were obtained as
previously described [37]. Cells lines were selected by treatment with
200 mg/L geneticin, which was removed 2 days before performing the
experiments.
2.3. Cell treatment
The medium from conﬂuent cultures was replaced with fresh
medium and 0.5 mM H2O2 was then added. After incubating for 2 h,
the mediumwas removed and the assays were performed. In order to
analyze lipid peroxidation, the culture medium was replaced with
Hanks solution prior to addition of 0.5 mM H2O2. After the incubation
period, both the culture medium and the cells from each plate weretransferred to tubes and subjected to the procedure described below
for malondialdehyde determination.
2.4. Malondialdehyde (MDA) determination
After cell treatment, 7 mLof a 0.4% (w/v) solution of 2-thiobarbituric
acid (TBA) in HCl 0.2 N/H2O (2:1) and 1 mL of a 0.2% (w/v) solution of
butylated hydroxytoluene in 95% ethanol were added to the samples
and the mixture was heated to 90 °C for 45 min, cooled on ice, and
extracted with isobutanol. The isobutanolic phase was injected through
a Shimadzu auto injector model SIL-10AD/VP (Shimadzu, Kyoto, Japan)
in a ShimadzuHPLC system, consisting of two LC-6ADpumps connected
to a Lichrosorb 10 RP-18 (Phenomenex, Torrance, CA) reversed-phase
column (250 mm×4.6 mm i.d. particle size 10 μm). The ﬂow rate of the
isocratic eluent (25 mM potassium phosphate buffer pH 7 with 40% of
methanol) was 1 mL/min. An RF-10A/XL ﬂuorescence detector was set
at an excitation wavelength of 515 nm and an emission wavelength of
550 nm. The data were processed using Shimadzu Class-VP 5.03 soft-
ware. Malonaldehyde-bisdiethylacetal was used for calibration of the
ﬂuorescence data, yielding a quantitative adduct of themalonaldehyde-
TBA product. The data were expressed as pmol of MDA normalized to
the protein content (in µg).
2.5. Comet assay
After treatment of the cells with H2O2 (0.5 mM), approximately 104
cells were suspended in 0.5% low-melting-point agarose in PBS at 37 °C
and placed on a glass microscope slide coated with a layer of 1.5%
normal-melting-point agarose inPBS. The slideswere immersed in cold-
lysing solution (2.5 M NaCl, 100 mMEDTA, 10 mMTris–HCl pH 10, 10%
dimethylsulfoxide, 1% Triton X-100) for 120 min at 4 °C. The slideswere
incubated for 45 min at 37 °C with 1 U Formamidopyrimidine DNA
glycosylase (Fpg) or Endonuclease III (Endo III). After enzymedigestion,
the slides were placed in an electrophoresis tank immersed in ice,
allowing the DNA to unwind for 20 min in alkaline solution (300 mM
NaOH and 1 mM EDTA, pH>13). Electrophoresis was then carried at
300 mA, 25V, for 20 min in the same solution. The slides were
neutralized with 0.4 M Tris–HCl buffer (pH 7.4), ﬁxed in 100% ethanol
and stained with ethidium bromide (20 µg/mL). Image analysis was
performed by ﬂuorescence microscopy using a Diaphot 300 (Nikon,
Tokyo, Japan) with a 510–560 nm ﬁlter and a 590 nm barrier. Fifty
comets on each slidewere visually analyzed using a Komet 6.0 software.
The results were expressed as tail intensity.
2.6. DNA extraction from cultured cell
The cells (4 × 107 cells) were centrifuged at 1500×g for 10 min and
eachpelletwas suspended in3 mLof lysis solution1%(w/v)TritonX-100,
320 mM sucrose, 5 mM MgCl2, 10 mM Tris–HCl, pH 7.5). This step was
repeated once and, after centrifugation at 1500×g for 10 min, the
nuclear pellets were suspended in 3 mL of 10 mM Tris–HCl buffer pH 8.0
containing 5 mM EDTA and 0.15 mM deferoxamine. The enzymes RNase
A (30 µL of a 10 g/L solution in 10 mM AcONa pH 5.2, heated for 15 min
at 100 °C), and RNase T1 (4 µL of a 20 U/µL solution in 10 mM Tris–HCl
buffer, pH 7.4 containing 1 mM EDTA and 2.5 mM deferoxamine) were
added together with 200 µL of a 10% (w/v) solution of SDS, and the
reaction mixture was incubated at 37 °C for 1 h. After incubation, 60 µL
of proteinase K (20 g/L)was added, followed by an additional incubation
at 37 °C for 1 h. After centrifugation at 5000×g for 15 min, the liquid
phase was collected and 2 mL of 40 mM Tris–HCl buffer, pH 8 containing
7.6 M NaI, 20 mM EDTA and 0.3 mM deferoxamine were added to the
cells, followed by the addition of 4 mL of isopropanol. The tube contents
were mixed well by inversion until a whitish precipitate formed. The
precipitate was collected by centrifugation at 5000×g for 15 min and
washed with 1 mL of 60% isopropanol (v/v), followed by 1 mL of 70%
ethanol (v/v). After an additional centrifugation at 5000×g for 15 min,
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The DNA concentration was measured spectrophotometrically at
260 nm, and its purity was assessed by ensuring an A260/A280≥1.7
using a UV-1650PC spectrophotometer (Shimadzu, Kyoto, Japan).
2.7. Enzymatic hydrolysis of DNA
Hydrolysis of 100 µg of DNAwas performed by addition of 2.0 µL of
1 M sodium acetate buffer, pH 5.0 and 1 U of nuclease P1 followed by
incubation at 37 °C for 30 min. After this incubation period, 4 µL of 1 M
Tris–HCl, buffer pH 7.4 and 4 µL of 500 mM potassium acetate buffer,
pH 7 containing 100 mMTris-acetate and 100 mMmagnesium acetate
were added, followed by addition of 3 U of alkaline phosphatase. The
reaction mixture was incubated at 37 °C for 1 h. The ﬁnal volume of
the sample was adjusted to 100 µL with water. The enzymes were
precipitated by immediate addition of one volume of chloroformat the
end of the hydrolysis. After centrifugation at 1000×g for 5 min, the
resulting aqueous layer was subjected to analysis. The DNA amounts
subjected to hydrolysis were 100 μg for analysis of 8-oxodGuo.
2.8. Analysis of 8-oxodGuo using high-performance liquid
chromatography/electrochemical detection (HPLC/EC)
Samples (100 µg) of digested DNA were injected into the HPLC/EC
system, which consisted of a Shimadzu model LC-10 AD pump
(Shimadzu, Tokyo, Japan) connected to a Luna C18 analytical column
(250 mm×4.6 mm i.d., 5 µm) (Phenomenex, Torrance, CA) main-
tained at 16 °C by a CTO-10AS VP column oven (Shimadzu, Tokyo,
Japan). The isocratic eluent was 25 mM potassium phosphate buffer
pH 5.5 and 8% methanol at a ﬂow rate of 1 mL/min. Coulometric
detection was provided by a Coulochem II detector (ESA, Chelmsford,
MA), and spectrophotometric detection by a Shimadzu SPD-10A
(Shimadzu, Tokyo, Japan). The potential of the electrode was set at
280 mV for detection of 8-oxodGuo. Elution of unmodiﬁed nucleo-
sides was simultaneously monitored by a Shimadzu SPD-10AV/VP UV
detector set at 254 nm. The Shimadzu Class-LC10 1.6 software was
used to calculate the peak areas. The molar ratio of 8-oxodGuo to 2′-
deoxyguanosine (dGuo) in each DNA sample was determined based
on coulometric detection at 280 mV for 8-oxodGuo and absorbance at
254 nm for dGuo in each injection.
2.9. Apoptosis
Apoptosis was measured by quantiﬁcation of sub-diploid nuclei
(sub-G1events) [38]. Brieﬂy, neuroblastoma cells (2×106 cells) in
control conditions or after treatment with 0.5 mM H2O2 for 2 h were
detached with trypsin and centrifuged at 1500×g for 5 min. The cell
pelletwas resuspended in400 µLofﬂuorescenthypotonic solution (0.1%
sodium citrate, 0.1% Triton X-100, 50 µg/mL propidium iodide). After
10 min, the cells were analyzed with a ﬂow cytometer. Alternatively,
the annexin VFITC assay was used to detect cells in apoptosis. Cell
suspensions were washed with annexin binding buffer (10 mMHEPES,
150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1,8 mM CaCl2). Supernatants
were removed and 100 µL annexin binding buffer with ﬂuorescein
isothiocyanate (FITC)-conjugated annexin-V (1 µM) was added to each
pellet. Cells were stained for 40 min in the dark at room temperature.
Immediately before collection, 400 µL of annexin binding buffer was
added to each sample. Cells were analyzed with a ﬂow cytometer
(FACScalibur-Becton Dickinson, San Jose, CA). Fluorescence was quan-
tiﬁed using the Facs Express 2.0 software.
2.10. Transient transfection of neuroblastomas for analysis of p53
activity using the reporter gene assay (luciferase activity)
Cells were grown in 24-well plates (105 cells/well) one day before
transfection. A total amount of 0.2 µg of DNA was used for each well(0.16 µg of p53-luc vector (Strategene, La Jolla, CA) and 0.04 µg of pRL-
TK vector, used as a control for transfection efﬁciency). The p53-Luc
vector contains the luciferase gene with a promoter that is responsive
to active p53. The pRL-TK vector contains the gene for renilla luciferase
under the thymidine kinase promoter. FuGene 6 (Roche, Indianapolis,
IN)was used as the transfection agent, andwas diluted in DMEM-Ham
F12 medium (0.6 µL of FuGene 6 per 20 µL of medium per well). The
vectors were added to the diluted FuGene 6 and incubated for 15 min
prior to addition of the mixture to cells. After 24 h, the medium was
replaced and the cells were treatedwith 0.5 mMH2O2 for 2 h. The cells
were lysedwith PLB buffer (Promega,Madison,WI), and the activity of
luciferase and renilla luciferase reporter genes was quantiﬁed using
a luminometer (Micro Lomat Plus) and the Promega System (Dual-
Luciferase Reporter Assay System).
2.11. Immunohistochemistry
Cells were seeded in 35-mm plates containing a glass coverslip
(MatTek, Ashland, MA), ﬁxed with paraformaldeyde (4%) for 15 min
at room temperature and permeabilized with 0.1% Triton X-100.
The samples were blocked for 1 h in 1% BSA in PBS and incubated for
2 h at 37 °C with sheep monoclonal anti-SOD1 antibody (Calbiochem,
Darmstadt, Germany), and then washed in blocking buffer and incu-
bated for 2 h with a goat anti-sheep antibody conjugated to Texas
Red (Invitrogen, Eugene OR). After rinsing in PBS, the cells were stained
with 10 µg/mL DAPI (Invitrogen-Molecular Probes, Eugene OR). The
same protocol was performed for nuclear images, except for the
permeabilization step. All images were acquired with a Zeiss LSM 510
Confocal Microscope.
2.12. Isolation and ﬂow cytometry analysis of nuclei
The medium was removed from each plate and the cells were
collected after trypsinization in calcium-free PBS. After centrifugation,
the cell pellet was resuspended in 1 mL of lysis buffer (320 mM
sucrose, 5 mMMgCl2, 1% (w/v) Triton X-100, 1 mM Tris–HCl, pH 7.8)
and incubated at 4 °C for 10 min. Nuclei were collected by centrifu-
gation at 3300×g for 15 min, and resuspended in 1 mL of incubation
buffer (320 mM sucrose, 5 mMMgCl2, 0.1% (w/v) Triton X-100, 1 mM
Tris–HCl, pH 7.8). Nuclei were incubated for 2 h at 37 °C with sheep
monoclonal anti-SOD1 antibody (Calbiochem, Darmstadt, Germany).
After incubation, the nuclei were washed and resuspended in incuba-
tion buffer containing goat anti-sheep antibody conjugated to Texas
Red and incubated for 2 h (Invitrogen, Eugene OR). The presence of
SOD1was analyzed by ﬂow cytometry using a Beckman Coulter FC500
MPL and MXP software.
2.13. Isolation and fractionation of nuclei
The medium was removed from each plate, and the cells were
collected in PBS. After centrifugation, the cell pellet was resuspended
in 100 μL of lysis buffer (100 mMNaCl, 300 mM sucrose, 3 mMMgCl2,
1 mM EGTA, 10 mM NaF, 10 mM Pipes, 0.5% Triton X-100 (v/v),
1.2 mM PMSF, 1 µg/mL aprotinin, 5 µg/mL leupeptin, 1 µg/mL
pepstatin) and incubated at 4 °C for 10 min. Nuclei were collected by
centrifugation at 3300×g for 15 min. The supernatant was separated
and, after 2 washes in lysis buffer, the nuclear pellet was resuspended
in 100 μL of nuclear lysis buffer (0.5% (w/v) sodium deoxycholate,
10 mM NaCl, 3 mM MgCl2, 10 mM NaF, 10 mM Tris, 1% Tween 20 (v/
v), 1.2 mM PMSF, 1 µg/mL aprotinin, 5 µg/mL leupeptin, 1 µg/mL
pepstatin). Soluble nuclear proteins were separated from the
chromatin by centrifugation at 20,000×g for 5 min. After 2 washes
in nuclear lysis buffer, the chromatin fractionwas incubated in 50 μL of
digestion buffer (50 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM
EGTA, 10 mM NaF, 10 mM Pipes, 0.5% Triton X-100 (v/v), 1.2 mM
PMSF, 1 µg/mL aprotinin, 5 µg/mL leupeptin, 1 µg/mL pepstatin,
Fig. 1. A) Level of DNA strand breaks in genomic DNA of parental SH-SY5Y cells (SH),
and cells transfected with wild-type SOD1 (WT), G93A mutant SOD1 (G93A) and H46R
mutant SOD1 (H46R), under control conditions and upon treatment with 1 U of Fpg or
Endo III. B) Level of DNA strand breaks in genomic DNA of SH-SY5Y cells and upon
treatment with 0.5 mM of H2O2 for 2 h. *Signiﬁcantly different from SH and WT under
the same condition, #signiﬁcantly different from G93A under control conditions and
+signiﬁcantly different from H46R under control conditions (p<0.001).
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sulfate (5 µL of a 2.5 M solution) was added to dissociate the proteins
from the DNA. After incubating for 5 min at room temperature, the
chromatin-associated proteins were separated by centrifugation at
20,000×g for 10 min. The protein content of each fraction was then
quantiﬁed.
2.14. Immunoblotting for SOD1, histone H1, and c-Fos
Nuclear-enriched protein fractions from SH-SY5Y cells were
subjected to 15% SDS-PAGE and transferred to a nitrocellulose mem-
brane by electroelution. Blots were blockedwith 5% nonfat drymilk in
TBS-T (0.05% Tween 20 in 50 mM Tris–HCl (pH 7.4), 150 mM NaCl)
and incubated overnight with a sheep polyclonal antibody speciﬁc for
human SOD1 (Calbiochem, Darmstadt, Germany) at 10 μg/mL in 0.1%
nonfat dry milk TBS-T. After the primary antibody incubation, the
blots were washed and incubated with peroxidase-conjugated
secondary antibody (10 ng/mL) (Calbiochem, Darmstadt, Germany).
The signal was developed using X-ray ﬁlm and the SuperSignal West
Pico Chemiluminescent Substrate kit (Pierce Biotechnology, Rockford,
IL). Immunoblots for histone-H1 and c-Fos were subsequently per-
formed in this order to assess the efﬁciency for the nuclear isolation
and fractionation protocol and to normalize for protein loading.
After overnight washing in TBS-T, the membrane was subjected to
overnight incubations in TBS-T containing 0.1% nonfat dry milk and
1 μg/mL of a mouse monoclonal antibody speciﬁc for human histone-
H1 (Upstate), followed by incubation with 2.5 μg/mL of a mouse
monoclonal antibody speciﬁc for human c-Fos (Calbiochem, Darm-
stadt, Germany). Incubation with the proper peroxidase-conjugated
secondary antibodies (10 ng/mL) (Calbiochem, Darmstadt, Germany)
was then carried out.
2.15. Superoxide dismutase activity in cytosolic and nuclear
protein extracts
Superoxide dismutase activity was assessed by spectrophotometric
analysis. Reactions were incubated at 37 °C in 50 mM sodium car-
bonate pH 10.2 with 100 µM diethylenetriaminepentaacetic acid
(DTPA), 100 µM xanthine, 56 µM nitro blue tetrazolium (NBT), 1 U/
mLof catalase and xanthine oxidase to obtain anNBT reduction speed of
0.0120±0.0002 Abs/min. NBT reductionwas followed at 560 nmusing
a UV-1650PC spectrophotometer (Shimadzu, Kyoto, Japan). SOD1
activity was quantiﬁed by inhibition of NBT reduction in the presence
of cytosolic and nuclear protein extracts (1–80 μg of total protein/mL).
Cytosolic SH-SY5Y cells protein extracts were obtained by freeze-
thawing. Nuclei were isolated using the method described above, and
then subjected to freeze-thawing to liberate nuclear proteins.
2.16. Peroxidase activity in cytosolic and nuclear protein extracts
Cytosolic SH-SY5Y cells protein extracts were obtained by freeze-
thawing. Nuclei were isolated using the method described above, and
then subjected to freeze-thawing to liberate nuclear proteins. Cytosolic
protein extracts (100 μg) and nuclear protein extracts (10 μg) were
incubated with 80 μM dihydrorhodamine (DHR), 100 μM DTPA, and
3 mM H2O2 in sodium phosphate buffer, pH 6.8 in the absence or
presence of 25 mM sodium bicarbonate. DHR oxidation to rhodamine
was followed at 500 nm for 5 min at 37 °C using a UV-1650PC
spectrophotometer (Shimadzu, Kyoto, Japan). The speed of enzymatic
DHR oxidation was obtained from the linear coefﬁcient of the plots.
2.17. Statistical analyses
Statistical analysis was performed by One-Way Analysis of Variance
(ANOVA) followed by the Student–Newman–Keuls Multiple Compar-ison as a post-test. Valueswere considered statistically signiﬁcantwhen
p<0.05.
3. Results
3.1. SH-SY5Y cells expressing G93A SOD1 demonstrate higher levels of
DNA damage and lipid peroxidation
SH-SY5Y cells transfected with G93A SOD1 (G93A) displayed 2-fold
increase in DNA strand breaks compared to control SH cells or cells
transfected with wild-type SOD (WT), as evidenced by the increased
damage index obtained in the comet assay (Fig. 1A). Addition of enzyme
(Fpg or Endo III) signiﬁcantly increased the level ofDNA strandbreaks in
G93A cells, an effectwhichwas not evidenced in the control cell neither
in the wild-type SOD1. For comparative purposes, experiments with
another model of FALS SOD1 mutant (H46R) cells, lacking SOD activity,
were also performed. These H46R cells showed higher levels of DNA
damage, however, the DNA damage displayed by H46R cell DNA is less
sensitive to Fpg or Endo III enzymes than that of G93A cells (Fig. 1A).
Treatment with H2O2 increased the tail intensity of all studied cells
(Fig. 1B).
The basal levels of 8-oxodGuo in the DNA of G93A cells were 3-fold
higher (∼60 8-oxodGuo/107 dGuo) than those of SH and WT cells
(∼208-oxodGuo/107 dGuo). H2O2 treatment caused no signiﬁcant
difference in 8-oxodGuo levels in the DNA of SH and WT cells, but
caused a 2-fold increase in the level of 8-oxodGuo in DNA of G93A
cells (Fig. 2). Moreover, higher levels of MDA (a classical marker of
lipid peroxidation) were also observed in G93A cells when compared
Fig. 2. Levels of 8-oxodGuo in genomic DNA of parental SH-SY5Y cells (SH), and of cells
transfected with the wild-type SOD1 (WT) or the G93A mutant SOD1 (G93A), under
control conditions and after treatment with 0.5 mM H2O2 for 2 h. *Signiﬁcantly
different from SH andWT under the same condition; #signiﬁcantly different from G93A
under control conditions (p<0.001). Inset: molecular structure of 8-oxodGuo linked to
a 2-deoxyribose residue.
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in the mutant cells upon H2O2 treatment (Fig. 3).
3.2. SH-SY5Y cells expressing G93A SOD1 display increased levels of
apoptosis and p53 activity
Accumulation of DNA damage and p53-activated apoptotic cell
deathwas evaluated in G93A,WT and SH cells. The involvement of p53
in activation of the apoptotic process was assessed by quantifying its
activity, irrespective of the level of p53 protein in the cells compared
to WT and control SH cells. G93A cells displayed increased (3-fold) of
p53 activity (Fig. 4A). A ca. 3-fold increase was also observed in the
levels of apoptosis measured by sub-G1 events (PI) (Fig. 4B) and by
phosphatidylserine translocation (annexin-V assay) (Fig. 4C) when
compared to WT and control SH cells. Hydrogen peroxide treatment
did not alter p53 activity in anyof these cell types neither apoptotic cell
death inWT and control SH cells (Fig. 4A and C). After H2O2 treatmentFig. 3. Levels of lipid peroxidation determined by MDA present in cellular extracts
obtained from parental SH-SY5Y cells (SH), and from cells transfected with the wild-
type SOD1 (WT) or the G93A mutant SOD1 (G93A), under control conditions and after
treatment with 0.5 mM H2O2 for 2 h. *Signiﬁcantly different from SH andWT under the
same condition; #signiﬁcantly different fromG93A under control conditions (p<0.001).
Fig. 4. Activity of p53 (A), apoptosis levels measured by sub-G1 population (PI) (B) and
by phosphatidylserine translocation of parental SH-SY5Y cells (SH), and of cells
transfected with the wild-type SOD1 (WT) or the G93A mutant SOD1 (G93A), under
control conditions and after treatment with 0.5 mM H2O2 for 2 h. *Signiﬁcantly dif-
ferent from SH and WT under the same condition; #signiﬁcantly different from G93A
under control conditions (p<0.001).an increase in sub-G1populationwas observed inG93A cells, since this
increase was not observed by the annexin-V assay, it appears that cell
death, in this case, occurs by necrosis (Fig. 4 B and C).
3.3. SH-SY5Y cells expressing G93A SOD1 exhibit increased levels of
SOD1 associated with chromatin
The presence of SOD1 in the nucleus of mammalian cells has been
previously described [39–41], suggesting that it may be a mediator of
DNA oxidation. In accordance, we conﬁrmed the presence of SOD1 in
the nuclei of SH-SY5Y cells by FACS and confocal microscopy (Fig. 5).
Furthermore, SOD1 immunoblots showed that control cells (SH) and
cells transfected with wild-type SOD1 (WT) and mutant G93A SOD1
(G93A) display SOD1 in the nucleus, as a soluble protein (Fig. 6).
Glucose 6-phosphatase activity was not detected in the nuclear frac-
tions, indicating that no cytosolic contamination occurred. Trans-
formed cell types (G93A, H46R and WT) displayed higher amounts of
SOD1 in the nucleus than control SH cells, probably due to the double
expression of SOD1 in themutant cells [37]. Sau et al. [42] showed that
G93A SOD1 was excluded from the nuclei of immortalized NSC34
Fig. 5. Immunoﬂuorescence and ﬂow cytometry results of (A) SH-SY5Y; (B) WT; (C) G93A and (D) H46R. Left panel presents confocal images showing nuclei stained with DAPI
(blue) and Texas Red labeled anti-SOD1 antibody (red). Right panel presents confocal images of nuclei stained with Texas Red labeled anti-SOD1 and representative FACS plots of
nuclei in the absence of antibody (grey line), nuclei only with secondary antibody (black line) and nuclei with primary and secondary antibodies (red line).
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Fig. 6.Western blot analysis of soluble nuclear proteins (Soluble Nuclear) and proteins
attached to the DNA (Chromatin) obtained from parental SH-SY5Y cells (SH), and from
cells transfected with the wild-type SOD1 (WT) or the G93A mutant SOD1 (G93A). The
c-Fos nuclear marker and the Histone H1 chromatin marker were used to assess protein
loading and the purity of the fractions.
Fig. 7. Superoxide dismutase activity in cytosolic (A) and nuclear (B) extracts obtained
from parental SH-SY5Y cells (SH), and from cells transfected with the wild-type SOD1
(WT) or the G93A mutant SOD1 (G93A). One SOD1 unit was deﬁned as the amount of
protein extract that promoted 50% inhibition in the rate of NBT reduction, as assessed
by absorbance at 560 nm. *Signiﬁcantly different from SH (p<0.001).
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high levels of human SOD1 expression in the murine cells used by
these authors. The human neuroblastoma cell line (SH-SY5Y) used in
the present work displayed only twice the normal SOD1 content. In
SH-SY5Y cells, SOD1 could also be isolated with the chromatin
proteins (Fig. 6). Contamination the chromatin protein fraction with
soluble nuclear protein is very unlikely, since the protocol clearly
assured sequestering of proteins tightly bound to DNA, such as
histones and did not result in isolation of Fos transcription factor.
Therefore, SOD1 associated with chromatin was observed for the ﬁrst
time, suggesting that it interacts strongly with DNA. Moreover, the
level of G93A SOD1 in chromatin was greater than that of wild-type
SOD1, whichmay indicate that themutant SOD1 has increased afﬁnity
for DNA.
3.4. Superoxide dismutase and peroxidase activity in the nucleus
Next, we compared the enzymatic activity of SOD1 in the cytosolic
and nuclear protein extracts of all three cell types (Figs. 7 and 8). Cells
transfected with either wild-type (WT) or mutant SOD1 (G93A)
showed increased (approximately 2-fold) superoxide dismutase
activity compared to control (SH) cells in both in the cytosol and
nucleus (Fig. 7A and B), in agreement with the augmented expression
of SOD1 in G93A and WT cells [37]. Peroxidase activity in these
neuroblastoma cells was monitored by oxidation of DHR upon addi-
tion of H2O2 in the presence and absence of bicarbonate (Fig. 8). The
results show increased peroxidase activity in cytosolic extracts from
G93A cells by 1.5 and 3-fold when compared to WT and SH cytosolic
extracts, respectively (Fig. 8A). Increased peroxidase activity by 2 and
3-fold was also observed in nuclear extracts obtained from G93A cells
compared to WT and SH nuclear extracts, respectively (Fig. 8B). This
bicarbonate-dependent peroxidase activity is most likely due to SOD1
[43] because the participation of redox-active transition-metal was
eliminated by the presence of DTPA in the assays, and because the
activity of other peroxidases is not modulated by bicarbonate [44,45].
4. Discussion
Here we show accumulation of oxidative DNA damage in G93A
cells as compared with SH and WT cells evaluated by 8-oxodGuo
levels measured by HPLC/EC. To gain insights into the nature of
oxidant species produced in cells, DNA damage was also evaluated by
the Comet Assay, quantifying DNA strand breaks in the presence and
absence of Fpg, a DNA glycosylase that recognizes the oxidized purine
8-oxoGua, as well as ring-opened purines or Endo III that converts
oxidized pyrimidines to strand breaks [46]. The ratio of strand breaks,
Fpg- and Endo III-sensitive lesions in G93A cells (1:3:3) indicates thatmore than one species contribute toDNAoxidation. They are likely to be
the hydroxyl radical and the carbonate radical because these species
present a complementary proﬁle of DNA damage. The hydroxyl radical
produces high yields of strand breaks and similar yields of oxidized
purines andpyrimidines (2.5:1:1) [47,48]whereas the carbonate radical
renders low yields of both strand breaks and pyrimidine oxidation [49].
The activity of DNA repair enzymes in ALS patients has been shown
to be lower [50] or higher [51,52] than that of normal individuals.
Although contradictory, these studies support that DNA damagemay be
an upstream event in motor neuron degeneration associated with ALS.
Several studies have implicated apoptotic pathways in the pathogenesis
of ALS, reviewed in [53,54]. The involvement of p53 protein in these
pathways has also been suggested [29–31]. Ciriolo et al. previously
showed that G93A cells display increased markers of apoptosis (DNA
fragmentation, cytochrome c release, Bcl-2 immunoreactivity and
caspase 3 activity), when compared to SH and WT cells [55]. Elevated
levels of p53 protein have also been shown in G93A cells [55]. Here
we show that accumulation of oxidative DNA damage in G93A cells
activates p53 protein, thereby triggering apoptosis. These results sug-
gest a role for the accumulation of oxidative DNA damage and p53
activation in the mechanism of motor neuron death in ALS.
The presence of SOD1 in the nucleus of mammalian cells has been
previously described [39–41]. Our results conﬁrmed this result in
both G93A and H46R cells by FACS and confocal microscopy analysis.
In addition, imunoblots of the chromatin fraction demonstrated for
the ﬁrst time that SOD1 is closely associated with DNA. These facts
make it possible to correlate the mutant SOD1 with the increased
levels of DNA damage observed in G93A cells. Once associated to
DNA, the G93A SOD1may directly promote DNA damage, possibly via
generation of oxidants by the mutant enzyme. We showed that
nuclear G93A SOD1 is active as superoxide dismutase and has in-
creased peroxidase activity in vivo, when compared to wild-type
SOD1. The increased levels of DNA damage observed upon H2O2
Fig. 8. Peroxidase activity in cytosolic (A) and nuclear (B) extracts obtained from
parental SH-SY5Y cells (SH), and from cells transfected with the wild-type SOD1 (WT)
or the G93A mutant SOD1 (G93A). One peroxidase unit was deﬁned as the amount of
protein extract that promoted rhodamine formation at a rate of 1 µM/min, as assessed
by absorbance at 500 nm. To determine peroxidase activity, the rate of DHR oxidation
in the absence of bicarbonate was deducted from the rate of DHR oxidation in the
presence of bicarbonate. Signiﬁcantly different from *SH or #WT (p<0.001).
Scheme 1. Proposed mechanisms of mutant SOD1 toxicity in mitochondria [16,17],
469L.F. Barbosa et al. / Biochimica et Biophysica Acta 1802 (2010) 462–471treatment were higher in G93A cells, which may also indicate aug-
mented peroxidase activity of the mutant SOD1 present in the
nucleus. Increased levels of DNA damage in ALS subjects and in
animal models have been previously described [32–36]. We propose
that the DNA damage observed in our cellular model could be a direct
result of SOD1 peroxidase activity.
It should be noted that puriﬁed wild-type and G93A mutant
SOD1 possess the same superoxide dismutase [56] and bicarbon-
ate-dependent peroxidase activities [57]. In cellular environments
and upon binding to biomolecules, however, these activities may
change in an unpredictable manner. Our results show that, in a
human cellular model, the FALS-mutant G93A SOD1 possesses
increased peroxidase activity in both the cytosol and nucleus.
G93A cells display increased (2-fold) intracellular generation of
reactive oxygen species when compared to SH and WT cells, as
previously suggested using DCF intracellular oxidation [55,58].
However, DCF oxidation is not speciﬁc for SOD1 peroxidase
activity, while DHR oxidation in the presence of bicarbonate,
shown here, is more speciﬁc. Analysis of cytosolic and nuclear
extracts allowed us to gather important information about SOD1
peroxidase activity in different cellular compartments, indicative
of different molecular targets for SOD1 peroxidase activity, such as
DNA.
The molecular events leading to motor neuron death in ALS
remains unknown, and the involvement of mutant SOD1 in these
processes remains poorly understood. The toxicity of FALS-mutant
SOD1 has been largely associated with its recruitment to the mito-
chondria [17–19] and endoplasmic reticulum (ER) [24,25]. In the
present work, we propose that recruitment of FALS-mutant SOD1
to the nucleus may be as toxic as is recruitment to the mitochondria
and ER since it can promote DNA damage and trigger apoptosis
via p53 activation (Scheme 1). DNA damage may play an impor-
tant role in the mechanism of motor neuron death observed inendoplasmic reticulum (ER) [23,24] and in the nucleus of a motor neuron cell.
470 L.F. Barbosa et al. / Biochimica et Biophysica Acta 1802 (2010) 462–471ALS patients, and the interaction of mutant and wild-type SOD1
with DNA deserves further investigation since it could provide
new insight into the complex connection between SOD1 and ALS
pathogenesis.
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